Press Release: European Medicines Agency updates on the review of Pandemrix and reports of narcolepsy

Author (Corporate)
Series Title
Series Details EMA/CHMP/588294/2010 (23.9.10)
Publication Date 23/09/2010
Content Type

Having reviewed all available data on the suspected link between narcolepsy and Pandemrix, The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) concluded, in September 2010, that the available evidence was insufficient to determine whether there was any link between Pandemrix and reports of narcolepsy, and that further studies were necessary to fully understand this issue.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/09/news_detail_001120.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp
Related Links
EMA: Press Release: EMA/CHMP/588294/2010 (23.9.10): European Medicines Agency updates on the review of Pandemrix and reports of narcolepsy http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/09/WC500096998.pdf
Subject Categories
Countries / Regions